Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00056173
Status:
COMPLETED
Last Update Posted:
2008-01-07
First Post:
2003-03-06
Brief Title:
Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma
Sponsor:
Aptose Biosciences Inc
Organization:
Aptose Biosciences Inc
Organization Data
Organization:
Aptose Biosciences Inc
Class:
INDUSTRY
Study ID:
L01-1409
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Aptose Biosciences Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Chicago | OTHER |
| Wake Forest University | OTHER |